Cibus (NASDAQ:CBUS) Earns Buy Rating from HC Wainwright

Cibus (NASDAQ:CBUS - Get Free Report)'s stock had its "buy" rating reiterated by equities research analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $25.00 target price on the stock. HC Wainwright's price objective indicates a potential upside of 334.78% from the stock's previous close.

A number of other analysts have also weighed in on CBUS. Canaccord Genuity Group restated a "buy" rating and issued a $20.00 target price on shares of Cibus in a research note on Tuesday, October 22nd. Alliance Global Partners dropped their target price on shares of Cibus from $25.00 to $23.50 and set a "buy" rating for the company in a research note on Tuesday, September 24th. Finally, Canaccord Genuity Group raised shares of Cibus to a "strong-buy" rating in a research note on Friday, July 19th.

Cibus Price Performance

CBUS stock traded up $0.47 during trading on Monday, hitting $5.75. The company had a trading volume of 215,863 shares, compared to its average volume of 137,424. The company has a fifty day moving average price of $4.08 and a two-hundred day moving average price of $8.75. Cibus has a fifty-two week low of $2.86 and a fifty-two week high of $23.18.

Cibus (NASDAQ:CBUS - Get Free Report) last posted its earnings results on Thursday, August 8th. The company reported ($1.14) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.81) by ($0.33). Cibus had a negative net margin of 10,724.78% and a negative return on equity of 23.84%. The firm had revenue of $0.84 million during the quarter, compared to the consensus estimate of $0.44 million. During the same quarter last year, the firm posted ($3.05) EPS. On average, analysts expect that Cibus will post -3.84 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Cibus

Several large investors have recently bought and sold shares of the company. SG Americas Securities LLC bought a new stake in Cibus in the 3rd quarter valued at $33,000. FineMark National Bank & Trust grew its stake in shares of Cibus by 24.3% during the 2nd quarter. FineMark National Bank & Trust now owns 20,488 shares of the company's stock worth $202,000 after acquiring an additional 4,000 shares in the last quarter. Squarepoint Ops LLC acquired a new stake in shares of Cibus in the second quarter valued at approximately $214,000. Rhumbline Advisers bought a new stake in shares of Cibus in the second quarter worth $221,000. Finally, Old West Investment Management LLC boosted its holdings in Cibus by 3.6% during the second quarter. Old West Investment Management LLC now owns 53,247 shares of the company's stock worth $524,000 after purchasing an additional 1,868 shares during the last quarter. Institutional investors own 33.81% of the company's stock.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.